Morgan Keegan Maintains Health Care REIT Outperform Rating (HCN)

Morgan Keegan maintained its Health Care REIT HCN Outperform rating in a research report published today. Morgan Keegan has previously given Health Care REIT at $55 price target. In the report, Morgan Keegan states, "We believe that Health Care REIT can sustain 4%-5% FFO growth long-term through internal growth, accretive acquisitions, and facility development. Our investment thesis calls for accretive new investments driving higher earnings, yielding a higher share price absent multiple expansion." Shares of Health Care REIT were at $48.31 in after hours trading at the time of posting, reflecting no change from Friday's market close.